Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$4.40 | -$4.40 | -$4.40 |
| Q2 2025 | 1 | -$3.80 | -$3.80 | -$3.80 |
| Q3 2025 | 1 | -$3.80 | -$3.80 | -$3.80 |
| Q4 2025 | 1 | -$3.80 | -$3.80 | -$3.80 |
iSpecimen Inc. last posted its earnings results on Monday, November 17th, 2025. The company reported $-0.48 earnings per share for the quarter, topping analysts' consensus estimates of $-3.8 by $3.32. The company had revenue of 106.59 K for the quarter and had revenue of 9.29 M for the year. iSpecimen Inc. has generated $-18 earnings per share over the last year ($-17.58 diluted earnings per share) and currently has a price-to-earnings ratio of -0.24. iSpecimen Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 30th, 2025 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/17/2025 | Q3 2025 | -$3.80 | -$0.48 | 3.32 | $3.33 M | $106.59 K |
| 08/14/2025 | Q2 2025 | -$3.80 | -$0.42 | 3.38 | $3.10 M | $713.14 K |
| 05/19/2025 | Q1 2025 | N/A | -$2.33 | N/A | N/A | $1.06 M |
| 04/14/2025 | Q4 2024 | -$4.00 | -$8.51 | -4.51 | N/A | $1.48 M |
| 11/07/2024 | Q3 2024 | -$3.80 | -$2.10 | 1.7 | $2.95 M | $2.66 M |
| 08/06/2024 | Q2 2024 | -$0.28 | -$3.72 | -3.44 | $2.88 M | $2.86 M |
| 05/07/2024 | Q1 2024 | -$0.27 | -$6.36 | -6.09 | N/A | $2.29 M |
| 03/13/2024 | Q4 2023 | -$0.24 | -$6.82 | -6.58 | N/A | $2.58 M |
| 11/02/2023 | Q3 2023 | -$0.35 | -$4.66 | -4.31 | $2.24 M | $2.78 M |
| 08/02/2023 | Q2 2023 | -$0.30 | -$7.71 | -7.41 | $3.07 M | $1.63 M |
| 05/04/2023 | Q1 2023 | -$0.32 | -$5.16 | -4.84 | $2.62 M | $2.95 M |
| 03/30/2023 | Q4 2022 | N/A | -$4.05 | N/A | $2.67 M | $2.96 M |
| 11/08/2022 | Q3 2022 | -$0.34 | -$6.96 | -6.62 | $2.45 M | $2.58 M |
| 08/04/2022 | Q2 2022 | -$0.27 | -$5.91 | -5.64 | $2.87 M | $2.34 M |
| 05/10/2022 | Q1 2022 | -$0.25 | -$5.50 | -5.25 | $2.78 M | $2.52 M |
| 03/22/2022 | Q4 2021 | N/A | -$5.41 | N/A | $3.50 M | $2.55 M |
| 11/04/2021 | Q3 2021 | N/A | -$4.46 | N/A | N/A | $2.72 M |
| 08/10/2021 | Q2 2021 | N/A | -$17.31 | N/A | N/A | $2.90 M |
| 03/30/2021 | Q1 2021 | N/A | -$84.67 | N/A | N/A | $2.96 M |
| 12/30/2020 | Q4 2020 | N/A | -$34.04 | N/A | N/A | $2.72 M |
iSpecimen Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 30th, 2025 based offlast year's report dates.
In the previous quarter, iSpecimen Inc. (:ISPC) reported $-0.48 earnings per share (EPS) to beat the analysts' consensus estimate of $-3.8 by $3.32.
The conference call for iSpecimen Inc.'s latest earnings report can be listened to online.
The conference call transcript for iSpecimen Inc.'s latest earnings report can be read online.
iSpecimen Inc. (:ISPC) has a recorded annual revenue of $9.29 M.
iSpecimen Inc. (:ISPC) has a recorded net income of $-12,497,805.iSpecimen Inc. has generated $-17.58 earnings per share over the last four quarters.
iSpecimen Inc. (:ISPC) has a price-to-earnings ratio of -0.24 and price/earnings-to-growth ratio is -0.02.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED